Clinical Trial Update: Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of Concept [Phase 4]

View source ↗

Summary

A Phase 4 trial of pimavanserin for insomnia in veterans with PTSD was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Posttraumatic Stress Disorder

Drugs mentioned

• Pimavanserin (pimavanserin)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Insomnia Chronic, Posttraumatic Stress Disorder | Phase 4 | Status: WITHDRAWN